Agh Mesa LLC
Agh Mesa LLC was paid $4.69M by Medicaid between Apr 2021 and Dec 2024, across 79 billing codes. Its largest line is 99283, emergency room visit (moderate) — 42% of everything it billed.
MESA, AZ 85204
Next to other Emergency Care Clinic/Center providers in Arizona
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 232 | $39K | |
| 2022 | 12,072 | $922K | |
| 2023 | 29,370 | $1.89M | |
| 2024incomplete | 28,725 | $1.84M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 42% | 10,639 | 9,998 | $1.95M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 25% | 5,253 | 4,980 | $1.19M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 12% | 852 | 828 | $565K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.8% | 1,234 | 1,184 | $461K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 4.6% | 436 | 425 | $217K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.3% | 2,179 | 2,073 | $202K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.9% | 493 | 483 | $90K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 27 | 26 | $8K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 27 | 26 | $1K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,588 | 1,506 | $811.52 |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 26 | 26 | $779.72 |
| 73130 | <1% | 274 | 265 | $514.56 |
67 more codes
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,721 | $316.54 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 849 | $241.50 |
| 80053 | Comprehensive metabolic panel | <1% | 3,760 | $202.64 |
| 81025 | <1% | 2,517 | $195.77 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,543 | $176.18 |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 958 | $153.28 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 69 | $137.61 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,905 | $133.18 |
| 71045 | Radiologic examination, chest; single view | <1% | 1,484 | $116.93 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,649 | $109.61 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 311 | $95.29 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 315 | $95.19 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,142 | $81.56 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 639 | $67.12 |
| 87631 | <1% | 1,147 | $61.07 | |
| 73630 | <1% | 335 | $58.06 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,095 | $54.95 |
| 81003 | <1% | 2,655 | $53.78 | |
| 82803 | <1% | 187 | $37.45 | |
| 73610 | <1% | 139 | $36.06 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 136 | $30.54 |
| 84702 | <1% | 310 | $26.48 | |
| 83605 | <1% | 204 | $20.27 | |
| 84484 | <1% | 852 | $18.60 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,298 | $14.89 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 13 | $10.35 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 432 | $5.65 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 17 | $5.39 |
| 82962 | <1% | 101 | $5.36 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,586 | $4.75 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,297 | $2.17 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 209 | $0.75 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,092 | $0.24 |
| 82565 | 0% | 54 | $0.00 | |
| 82947 | 0% | 54 | $0.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 380 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 550 | $0.00 |
| 90715 | 0% | 66 | $0.00 | |
| 74018 | 0% | 53 | $0.00 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 0% | 17 | $0.00 |
| 87634 | 0% | 182 | $0.00 | |
| 73562 | 0% | 39 | $0.00 | |
| 84520 | 0% | 54 | $0.00 | |
| 87186 | 0% | 13 | $0.00 | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 0% | 12 | $0.00 |
| 73030 | 0% | 13 | $0.00 | |
| 80076 | 0% | 15 | $0.00 | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 0% | 14 | $0.00 |
| 80306 | 0% | 13 | $0.00 | |
| 82550 | 0% | 89 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 379 | $0.00 |
| 96361 | Intravenous infusion, hydration; each additional hour | 0% | 723 | $0.00 |
| 96376 | 0% | 40 | $0.00 | |
| J3490 | Unclassified drugs | 0% | 950 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 155 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 3,933 | $0.00 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 496 | $0.00 |
| 80051 | 0% | 89 | $0.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 70 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 1,197 | $0.00 |
| 82553 | 0% | 353 | $0.00 | |
| 87428 | 0% | 58 | $0.00 | |
| 76830 | Ultrasound, transvaginal | 0% | 12 | $0.00 |
| 93971 | 0% | 24 | $0.00 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 0% | 55 | $0.00 |
| 85379 | 0% | 237 | $0.00 | |
| 87077 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Agh Laveen LLC | Laveen, AZ | $109.33M |
| Agh Mesa LLC | Mesa, AZ | $28.01M |
| Agh Laveen LLC | Glendale, AZ | $14.88M |
| Agh Laveen LLC | Goodyear, AZ | $4.04M |
| Agh Laveen LLC | Surprise, AZ | $3.48M |
| Agh Laveen LLC | Glendale, AZ | $3.40M |
| Agh Mesa LLC | Tempe, AZ | $3.34M |
| Agh Mesa LLC | Chandler, AZ | $2.76M |
| Agh Mesa LLC | Mesa, AZ | $2.66M |
| Agh Mesa LLC | San Tan Valley, AZ | $2.32M |
| Agh Mesa LLC | Phoenix, AZ | $1.74M |
| Agh Mesa LLC | Chandler, AZ | $1.12M |
| Agh Mesa LLC | Gilbert, AZ | $978K |
| Agh Laveen LLC | Mesa, AZ | $293K |
| Agh Laveen LLC | Chandler, AZ | $259K |
| Agh Laveen LLC | Phoenix, AZ | $184K |
| Agh Laveen LLC | Mesa, AZ | $167K |
| Agh Laveen LLC | Gilbert, AZ | $160K |
| Agh Laveen LLC | Chandler, AZ | $41K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.